Current role
Hans-Peter Gerber
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Sutro Biopharma, Inc. (STRO)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Sutro Biopharma, Inc. (STRO) | Chief Scientific Officer | $527,532 | $942,902 |
| 2024 | Sutro Biopharma, Inc. (STRO) | Chief Scientific Officer | $512,500 | $1,153,932 |
Recent activity
No call appearances or filed executive changes recorded yet.